X @Forbes
Christian Angermayer has cemented his place in psychedelics by selling biotech AtaiBeckley to Eli Lilly in the biggest acquisition in the industry. "The future is psychedelic, and it is here," he says. Full story: https://t.co/mCjXJByuM9📸: Levon Biss for Forbes https://t.co/iuednTpJuM ...